[WS(P)08] Infection immunity 1

[WS08-05-P] Diminished Neutralization activity against the XBB1.5 Strain Post 6-month COVID-19 mRNA Booster Vaccination: Automated Pseudovirus-Based Neutralization Assay for Large-scale serosurveillance

^○Chieko Makino Okamura^1,2, Tianchen Zhao^3,4, Yuta Tani³, Morihito Takita^3,4, Chika Yamamoto^3,4, Hiroki Yoshimura^3,4, Harumichi ishigame^1,5, Takaharu Ueno⁶, Kazu Okuma⁶, Masatoshi Wakui⁷, Masaharu Tsubokura^3,4, Hidehiro Fukuyama^1,2,8,9 (1.Division of Immunology, Near InfraRed Photo-ImmunoTherapy Research Institute, Kansai Medical University, 2.Infectious Diseases Research Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan, 3.General Incorporated Association for Comprehensive Disaster Health Management Research Institute, Tokyo, Japan, 4.Department of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima, Japan, 5.Laboratory for Tissue Dynamics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan, 6.Department of Microbiology, Kansai Medical University, School of Medicine, Hirakata, Osaka, Japan, 7.Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan, 8.Cell Integrative Science Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan, 9.INSERM EST, Strasbourg, France)

キーワード：

COVID-19、SARS-CoV2、mRNA vaccine、Neutralization activity

閲覧にはパスワードが必要です

ログイン

または